Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer

OBJECTIVE: To evaluate the efficacy and safety of niraparib in Japanese women with heavily pretreated ovarian cancer. METHODS: This Phase 2 open-label, single-arm study enrolled Japanese women with homologous recombination deficiency-positive relapsed, high-grade serous ovarian, fallopian tube, or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Aikou, Kondo, Eiji, Nakamura, Toshiaki, Yanagida, Satoshi, Hamanishi, Junzo, Harano, Kenichi, Hasegawa, Kosei, Hirasawa, Takeshi, Hori, Kensuke, Komiyama, Shinichi, Matsuura, Motoki, Nakai, Hidekatsu, Nakamura, Hiroko, Sakata, Jun, Tabata, Tsutomu, Takehara, Kazuhiro, Takekuma, Munetaka, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Soeda, Junpei, Suri, Ajit, Aoki, Daisuke, Sugiyama, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930437/
https://www.ncbi.nlm.nih.gov/pubmed/33327047
http://dx.doi.org/10.3802/jgo.2021.32.e16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930437/
https://www.ncbi.nlm.nih.gov/pubmed/33327047
http://dx.doi.org/10.3802/jgo.2021.32.e16

Ejemplares similares